170 related articles for article (PubMed ID: 31792328)
1. DPP8 is a novel therapeutic target for multiple myeloma.
Sato T; Tatekoshi A; Takada K; Iyama S; Kamihara Y; Jawaid P; Rehman MU; Noguchi K; Kondo T; Kajikawa S; Arita K; Wada A; Murakami J; Arai M; Yasuda I; Dang NH; Hatano R; Iwao N; Ohnuma K; Morimoto C
Sci Rep; 2019 Dec; 9(1):18094. PubMed ID: 31792328
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors.
Huan Y; Jiang Q; Liu JL; Shen ZF
J Pharmacol Toxicol Methods; 2015; 71():8-12. PubMed ID: 25464020
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis.
Matheeussen V; Waumans Y; Martinet W; Van Goethem S; Van der Veken P; Scharpé S; Augustyns K; De Meyer GR; De Meester I
Basic Res Cardiol; 2013 May; 108(3):350. PubMed ID: 23608773
[TBL] [Abstract][Full Text] [Related]
4. DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.
Kikuchi S; Wada A; Kamihara Y; Okazaki K; Jawaid P; Rehman MU; Kobayashi E; Susukida T; Minemura T; Nabe Y; Iwao N; Ozawa T; Hatano R; Yamada M; Kishi H; Matsuya Y; Mizuguchi M; Hayakawa Y; Dang NH; Sakamoto Y; Morimoto C; Sato T
Cells; 2023 Apr; 12(7):. PubMed ID: 37048172
[TBL] [Abstract][Full Text] [Related]
5. Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor.
Wu JJ; Tang HK; Yeh TK; Chen CM; Shy HS; Chu YR; Chien CH; Tsai TY; Huang YC; Huang YL; Huang CH; Tseng HY; Jiaang WT; Chao YS; Chen X
Biochem Pharmacol; 2009 Jul; 78(2):203-10. PubMed ID: 19439267
[TBL] [Abstract][Full Text] [Related]
6. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia.
Johnson DC; Taabazuing CY; Okondo MC; Chui AJ; Rao SD; Brown FC; Reed C; Peguero E; de Stanchina E; Kentsis A; Bachovchin DA
Nat Med; 2018 Aug; 24(8):1151-1156. PubMed ID: 29967349
[TBL] [Abstract][Full Text] [Related]
7. Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells.
Zhang Y; Li K; Li Y; Zhao W; Wang L; Chen Z; Ma X; Yao T; Wang J; Dong W; Li X; Tian X; Fu R
Pharmacol Res; 2021 Jul; 169():105630. PubMed ID: 33932609
[TBL] [Abstract][Full Text] [Related]
8. Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific Lead.
Benramdane S; De Loose J; Beyens O; Van Rymenant Y; Vliegen G; Augustyns K; De Winter H; De Meester I; Van der Veken P
ChemMedChem; 2022 Aug; 17(15):e202200097. PubMed ID: 35760756
[TBL] [Abstract][Full Text] [Related]
9. Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.
Kang NS; Ahn JH; Kim SS; Chae CH; Yoo SE
Bioorg Med Chem Lett; 2007 Jul; 17(13):3716-21. PubMed ID: 17462890
[TBL] [Abstract][Full Text] [Related]
10. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues.
Harstad EB; Rosenblum JS; Gorrell MD; Achanzar WE; Minimo L; Wu J; Rosini-Marthaler L; Gullo R; Ordway ND; Kirby MS; Chadwick KD; Cosma GN; Moyer CF
Regul Pept; 2013 Sep; 186():26-35. PubMed ID: 23850796
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins.
Liu J; Huan Y; Li C; Liu M; Shen Z
Acta Pharm Sin B; 2014 Apr; 4(2):135-40. PubMed ID: 26579375
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
Lankas GR; Leiting B; Roy RS; Eiermann GJ; Beconi MG; Biftu T; Chan CC; Edmondson S; Feeney WP; He H; Ippolito DE; Kim D; Lyons KA; Ok HO; Patel RA; Petrov AN; Pryor KA; Qian X; Reigle L; Woods A; Wu JK; Zaller D; Zhang X; Zhu L; Weber AE; Thornberry NA
Diabetes; 2005 Oct; 54(10):2988-94. PubMed ID: 16186403
[TBL] [Abstract][Full Text] [Related]
13. Non-Specific Inhibition of Dipeptidyl Peptidases 8/9 by Dipeptidyl Peptidase 4 Inhibitors Negatively Affects Mesenchymal Stem Cell Differentiation.
Torrecillas-Baena B; Camacho-Cardenosa M; Quesada-Gómez JM; Moreno-Moreno P; Dorado G; Gálvez-Moreno MÁ; Casado-Díaz A
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510747
[TBL] [Abstract][Full Text] [Related]
14. Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer.
Ross B; Krapp S; Augustin M; Kierfersauer R; Arciniega M; Geiss-Friedlander R; Huber R
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1437-E1445. PubMed ID: 29382749
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?
Van Goethem S; Matheeussen V; Joossens J; Lambeir AM; Chen X; De Meester I; Haemers A; Augustyns K; Van der Veken P
J Med Chem; 2011 Aug; 54(16):5737-46. PubMed ID: 21711053
[TBL] [Abstract][Full Text] [Related]
16. Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
Chowdhury S; Chen Y; Yao TW; Ajami K; Wang XM; Popov Y; Schuppan D; Bertolino P; McCaughan GW; Yu DM; Gorrell MD
World J Gastroenterol; 2013 May; 19(19):2883-93. PubMed ID: 23704821
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation.
Han R; Wang X; Bachovchin W; Zukowska Z; Osborn JW
Sci Rep; 2015 Aug; 5():12348. PubMed ID: 26242871
[TBL] [Abstract][Full Text] [Related]
19. Grassypeptolides as natural inhibitors of dipeptidyl peptidase 8 and T-cell activation.
Kwan JC; Liu Y; Ratnayake R; Hatano R; Kuribara A; Morimoto C; Ohnuma K; Paul VJ; Ye T; Luesch H
Chembiochem; 2014 Apr; 15(6):799-804. PubMed ID: 24591193
[TBL] [Abstract][Full Text] [Related]
20. Decrease of the pro-inflammatory M1-like response by inhibition of dipeptidyl peptidases 8/9 in THP-1 macrophages - quantitative proteomics of the proteome and secretome.
Suski M; Wiśniewska A; Kuś K; Kiepura A; Stachowicz A; Stachyra K; Czepiel K; Madej J; Olszanecki R
Mol Immunol; 2020 Nov; 127():193-202. PubMed ID: 32998073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
